[Evaluation of the efficacy and safety of a complex antiviral drug based on antibodies in the treatment of adult patients with acute respiratory viral infection].
R F KhamitovV V NikiforovA A ZaitsevI N TragiraPublished in: Terapevticheskii arkhiv (2022)
Raphamin promotes significant decrease, practically by a day, the duration of ARVI, including influenza.